Matthew Labbe is an accomplished engineer with a background in chemical engineering, holding a Bachelor's degree from the University of Massachusetts Amherst. Currently serving as Engineer II at Moderna since August 2021, Labbe leads lipid nanoparticle commercial tech transfer activities and new technology development for the Individualized Neoantigen Therapy program. Previous roles include Engineer 1 in lipid nanoparticle process development at Moderna, where significant contributions were made to next-generation manufacturing processes, and Process Development Engineer at HP. Labbe's experience also encompasses research and development positions, including a research assistant role at Perry Group and various internships focusing on process optimization and business development. Notable skills include expertise in process engineering, project presentation, and team collaboration.
This person is not in the org chart
This person is not in any teams
This person is not in any offices